Evidence map›Paper›PMID 40608661›Full record

ArticleCadernos de saude publica2025

[Pharmaceutical services in expanded access, compassionate use, and post-trial access: the perspective of clinical researchers].

Maria Bárbara Faria Cardoso da Silva, Cecilia Ferreira da Silva, Mario Jorge Sobreira da Silva

Abstract readEnglish Abstract
In one paragraph

Article in Cadernos de saude publica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maria Bárbara Faria Cardoso da SilvaInstituto Nacional de Câncer, Rio de Janeiro, Brasil.ORCID 0000-0002-7901-9112
Cecilia Ferreira da SilvaInstituto Nacional de Câncer, Rio de Janeiro, Brasil.ORCID 0000-0003-4691-4505
Mario Jorge Sobreira da SilvaInstituto Nacional de Câncer, Rio de Janeiro, Brasil.ORCID 0000-0002-0477-8595

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study sought to understand the flows of pharmaceutical services and the contributions of pharmacists in expanded access programs, compassionate use, and the post-trial access of medications, from the perspective of healthcare professionals experienced in clinical research. A organizacional case study was conducted at an oncology hospital in Rio de Janeiro, followed by the administration of a questionnaire to pharmacists from different regions of Brazil. The study was grounded in Denzin's theoretical framework of interpretive interactionism. Data were analyzed using an explanatory construction technique and interpreted via thematic content analysis. In total, three thematic axes emerged: the operationalization of pharmaceutical services; the clinical responsibilities of the pharmacist; and continuous quality improvement. A total of ten professionals participated in the organizational case study phase, and 12 responded to the questionnaire. The results indicated convergent needs, underscoring the importance of optimizing logistical and operational activities, drug therapy monitoring, continuing education, pharmacovigilance, information dissemination, and healthcare quality. These findings have the potential to inform future guidelines to enhance program processes, address regulatory gaps, and provide better support for healthcare.

Indexed as

Compassionate Use TrialsHealth Services AccessibilityPharmaceutical ServicesPharmacistsPharmacy Service, HospitalResearch PersonnelBrazilHumansQuality ImprovementSurveys and Questionnaires

Identifiers

PMID40608661
PMCPMC12212296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.